PATENT CLAIM ANALYSIS

Application Number: 16196726
Application Type: Utility
Filing Date: 2018-11
Publication Date: 2019-03
Patent Classification: ["514", "401000"]

Abstract:
The present disclosure provides novel formulations for treating foot or hand pain by topically administering a sympathomimetic drug, particularly oxymetazoline, to the skin of the foot or hand.

Claim (Index 6):
The method of  claim 1 , wherein the transdermal penetrant is pentane 1,5-diol, N-dodecyl-2-pyrrolidone and its acetate analogue, fatty acids, oleic acid, terpenes, esters, isopropyl myristate, khellin and khellin analogues, methyl nicotinate, MSM-decylmethylsulfoxide, diethylene glycol, citric acid, pyruvic acid, phenoxyethanol, transcutol, phosphatidyl choline, a medium chain triglyceride oil (MCT oil) water or combinations thereof.

Metadata:
- Claim Count in Document: 39.0
- Percentile: 98.0
- Lexical Diversity: 1.19231
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14231096', '13262704', '14027033', '15490011', '15498991']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7297711069627915
- 35 USC 102 Novelty (BERT): 0.6053398250484479
- Combined Prediction Score: 0.7173279787713571
- Mean Citation Score: 239.13687400000003
- Max Citation Score: 512.20874
- Similarity Product: 499.9575925149417

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test